␥-Secretase is a multiprotein complex composed of presenilin (PS), nicastrin (NCT), Aph-1, and Pen-2, and it catalyzes the final proteolytic step in the processing of amyloid precursor protein to generate amyloid-␤. Our previous results showed that tumor necrosis factor-␣ (TNF-␣) can potently stimulate ␥-secretase activity through a c-Jun N-terminal kinase (JNK)-dependent pathway. Here, we demonstrate that TNF-␣ triggers JNK-dependent serine/threonine phosphorylation of PS1 and NCT to stimulate ␥-secretase activity. Blocking of JNK activity with a potent JNK inhibitor (SP600125) reduces TNF-␣-triggered phosphorylation of PS1 and NCT. Consistent with this, we show that activated JNKs can be copurified with ␥-secretase complexes and that active recombinant JNK2 can promote the phosphorylation of PS1 and NCT in vitro. Using site-directed mutagenesis and a synthetic peptide, we clearly show that the Ser 319 Thr 320 motif in PS1 is an important JNK phosphorylation site that is critical for the TNF-␣-elicited regulation of ␥-secretase. This JNK phosphorylation of PS1 at Ser 319 Thr 320 enhances the stability of the PS1 C-terminal fragment that is necessary for ␥-secretase activity. Together, our findings strongly suggest that JNK is a critical intracellular mediator of TNF-␣-elicited regulation of ␥-secretase and governs the pivotal step in the assembly of functional ␥-secretase.
INTRODUCTION
Extensive deposition of extracellular amyloid-␤ (A␤) peptides, generated by secretase-mediated proteolysis of amyloid precursor protein (APP), is regarded as the foremost pathological hallmark of Alzheimer's disease (AD) in affected brains (Selkoe, 2001) . The sequential actions of ␤-and ␥-secretases catalyze the production of A␤, and both proteases have been regarded as prime therapeutic targets in AD (Esler and Wolfe, 2001) . Moreover, understanding the molecular mechanisms governing the enzymatic activities of these secretases should shed new light on the pathogenesis of AD.
␥-Secretase is a high-molecular-weight multimeric protein complex with aspartyl protease activity that is required for the cleavage of a wide range of type I membrane proteins, including APP and Notch receptors . The major constituents of this protease include presenilins (PS1 and PS2), nicastrin (NCT), Aph-1, and Pen-2 (Iwatsubo, 2004) . Consistent with the A␤-centered pathogenesis of AD, all the mutations in PSs that are associated with familial type AD (FAD) have been shown to favor the generation of a more amyloidogenic A␤ species, A␤42, and lead to early onset of AD (Tanzi and Bertram, 2005) . These FAD-linked PS mutations apparently affect the ␥-and -cleavages of APP through reduced proteolytic activity of ␥-secretase (Bentahir et al., 2006) , resulting in a decrease in total A␤ but an increase in the ratio of A␤42/A␤40 (De Strooper, 2007; Wolfe, 2007) . In addition, these FAD-linked mutations can also lead to increased oxidative insults; it would then be possible that oxidative damage in AD could have a greater impact in the pathogenesis of this disease than A␤ does. The recently proposed alternate amyloid hypothesis, in stark contrast to the amyloid cascade hypothesis, argues that A␤ could play a neuroprotective role and that the declines in A␤ production due to FAD mutations would bleach antioxidant potential and render neurons more vulnerable to oxidative insults (Lee et al., 2004 (Lee et al., , 2006 . Thus, it is imperative to determine the molecular mechanism(s) governing the homeostasis of endogenous ␥-secretase activity and A␤ production. These studies could then expedite the identification of novel therapeutic targets for AD.
We previously demonstrated that proinflammatory cytokines, including interferon-␥ (IFN-␥), interleukin-1␤ (IL-1␤), and tumor necrosis factor-␣ (TNF-␣), can stimulate ␥-secre-tase activity and A␤ production through a c-Jun N-terminal kinase (JNK)-dependent mitogen-activated protein kinase (MAPK) pathway (Liao et al., 2004) . Our findings thus support with a model in which extensive activation of JNK plays a pivotal role in the pathogenesis of AD (Zhu et al., 2001 (Zhu et al., , 2004a . Given that fibrillar A␤ can stimulate microglia to promote the release of both TNF-␣ and IL-1␤ (Combs et al., 2001; Bamberger et al., 2003) , our data also suggest that cytokine-elicited activation of ␥-secretase by the JNK pathway could constitute a positive feedback for the A␤-induced neurotoxicity during the pathogenesis of AD.
It is clear that JNK acts as a positive regulator of ␥-secretase, but the molecular mechanism underlying how JNK transduces its signal to this protease remains elusive. JNK has been shown to phosphorylate APP at Thr 668 (Reynolds et al., 2000) , resulting in an enhanced APP processing by ␥-secretase (Vingtdeux et al., 2005) . It is also possible that ␥-secretase itself is subject to phosphorylation by JNK. We thus hypothesize that cytokine-elicited signaling might converge on JNK whereby ␥-secretase activity can then be regulated. Here, we present direct evidence suggesting that TNF-␣-elicited stimulation of ␥-secretase is mediated through JNK-dependent phosphorylation of PS1 and NCT, resulting in the enhanced stability of PS1 C-terminal fragment (PS1-CTF) to facilitate the formation of functional ␥-secretase complexes. These findings will pave the way for the identification of endogenous factors engaged in the regulation of ␥-secretase-catalyzed proteolysis of APP.
MATERIALS AND METHODS

Reagents
BCA protein assay reagent kit, SuperSignal West Dura Extended Duration substrate, and Pico chemiluminescent substrate were purchased from Pierce (Rockford, IL). Mouse anti-JNK1 antibody was from R&D Systems (Minneapolis, MN). Rabbit anti-Notch(Val 1744 ) antibody, rabbit anti-SAPK/JNK MAPK antibody, mouse anti-phospho-SAPK/JNK antibody, and rabbit anti-JNK2 were purchased from Cell Signaling Technology (Beverly, MA). and rabbit anti-JNK3 was from Abgent (San Diego, CA). Rabbit anti-His probe (H-15) antibody, rabbit anti-GAPDH (FL-335) antibody, horseradish peroxidase (HRP)-conjugated anti-rabbit IgG, HRP-conjugated anti-rat IgG, and HRP-conjugated anti-mouse IgG were from Santa Cruz Biotechnology (Santa Cruz, CA), and Dual-Glo luciferase assay reagents, Steady-Glo luciferase assay reagents, and pRL-TK vector were from Promega (Madison, WI). Lipofectamine 2000 transfection reagent and DMEM were from Invitrogen (Carlsbad, CA). Fetal bovine serum (FBS) was from Biological Industries (Kibbutz Beit Haemek, Israel) . Human A␤40 colorimetric ELISA kit was from BioSource International (Camarillo, CA). TNF-␣ was from PeproTech Asia (Rehovot, Israel). HRP-conjugated anti-mouse IgG and ECL Western blotting detection reagents were from GE Healthcare (Waukesha, WI). FuGENE 6 transfection reagent, Expand long template PCR system, the Complete protease inhibitor cocktail, and the PCR nucleotide mixture were from Roche Applied Science (Indianapolis, IN). Mouse anti-phospho-Ser/Thr-Pro (MPM-2) antibody and active recombinant human JNK2 were from Upstate Biotechnology (Lake Placid, NY). Rat anti-presenilin-1 mAb, rabbit anti-APP C-terminal antibody, rabbit anti-presenilin-1-loop antibody, and mouse anti-A␤ protein (6E10) antibody were purchased from Chemicon (Temecula, CA). Rabbit anti-nicastrin was from Calbiochem (La Jolla, CA). The QuikChange site-directed mutagenesis kit was from Stratagene (La Jolla, CA). All other reagents were at least reagent grade and obtained from standard suppliers.
Cell Culture and Cell Lines
Human embryonic kidney cells (HEK293) and Chinese hamster ovary cells were maintained in DMEM supplemented with 10% FBS and 0.1 mg/ml penicillin and streptomycin. T-REx293 cells were purchased from Invitrogen and cultured in DMEM supplemented with 10% FBS and 5 g/ml blasticidin. The generation of stably transfected cell lines, T16, T20, N7, and ␥-30, was described previously Liao et al., 2004; Bakshi et al., 2005) . HEK293-derived T16 cells were stably transfected with tetracycline-inducible Gal4/VP16-tagged full-length hAPP695 and a Gal4 promoter-driven firefly luciferase reporter gene. HEK293-derived T20 cells were stably transfected with tetracycline-inducible Gal4/VP16-tagged APP-C99 (a direct ␥-secretase substrate) and a Gal4 promoter-driven firefly luciferase reporter gene. HEK293-derived N7 cells expressed mouse N⌬E, a direct ␥-secretase substrate. CHO-derived ␥-30 cells overexpressed exogenous hPS1, hemagglutinin (HA)-tagged Aph1, and FLAG-tagged Pen-2. CHO-derived ␥NCT-36 cells overexpressed exogenous hPS1, His-tagged NCT, HA-tagged Aph1, and FLAG-tagged Pen-2. Cells were incubated in a humidified incubator at 37°C in 5% CO 2 .
Transient Transfection of Mammalian Cells
Transfection of HEK293, T20, ␥-30, and ␥NCT-36 cells was performed using FuGENE 6 transfection reagent or Lipofectamine 2000 transfection reagent as described by the manufacturers. Cells were plated onto six-well microplates or 10-cm plates and grown to ϳ60 -80% confluency before transfection. On the day of transfection, the culture medium was replaced with fresh 2 ml/ well or 10 ml/plate of DMEM supplemented with 10% FBS. DNA constructs (1 g) and pRL-TK (0.1 g) were diluted in 100 l of serum-free DMEM and mixed with 3 l of FuGENE 6 or Lipofectamine 2000, followed by incubation at room temperature for 15 min. Transfection mixtures were added dropwise into cell culture medium and incubated at 37°C for 24 h. Transfected cells were harvested by PBS containing 20 mM EDTA and lysed with 1ϫ passive lysis buffer (PLB, Promega, Madison, WI) or CHAPSO lysis buffer (50 mM Tris-HCl, pH 8.0, 1% CHAPSO, 150 mM NaCl, 25 mM ␤-glycerophosphate, 1 mM Na 3 VO 4 , and the Complete protease inhibitor cocktail). Clarified lysates were subject to luciferase assay using the Dual-Glo luciferase assay reagent kit for the measurement of ␥-secretase activity or affinity pulldown using HISSelect Cobalt Affinity Gel (Sigma, St. Louis, MO) for the isolation of ␥-secretase complexes. Protein content of lysates was determined by the BCA protein assay reagent kit.
Transfection of Small Interfering RNAs Targeting JNK1, JNK2, and JNK3
Small interfering RNA (siRNA) duplex oligoribonucleotides against human JNK1 (si-JNK1), JNK2 (si-JNK2), and JNK3 (si-JNK3) were chemically synthesized by Invitrogen. The target sequences for si-JNK1 were 5Ј-GGA GCU CAA GGA AUA GUA U-3Ј (sense strand) and 5Ј-AUA CUA UUC CUU GAG CUC C-3Ј (antisense strand); for si-JNK2, 5Ј-GCU CUG CGU CAC CCA UAC A-3Ј (sense strand) and 5Ј-UGU AUG GGU GAC GCA GAG C-3Ј (antisense strand); and for si-JNK3, 5Ј-GGG AUU UAA AAC CAA GUA A-3Ј (sense strand) and 5Ј-UUA CUU GGU UUU AAA UCC C-3Ј (antisense strand). The human GAPDH siRNAs and nonspecific scrambled siRNAs were from Ambion (Austin, TX). Gene-targeting siRNA oligos (100 pmol; for individual knockdown of JNK1, JNK2, or JNK3) were mixed with nonspecific scramble siRNAs (100 pmol) and transfected into T20 cells by using the Lipofectamine 2000 transfection reagent (Invitrogen) according to the manufacturer's instructions. Additionally, two gene-targeting siRNA oligos (100 pmol each; for combinatorial knockdown of JNK1ϩJNK2, JNK1ϩJNK3, or JNK2ϩJNK3) were mixed and transfected into T20 cells. T20 cells (2.5 ϫ 10 4 /well) were plated in 12-well microplates and transfected with siRNAs for 24 h, followed by an additional incubation with culture medium containing 1 g/ml tetracycline in the presence or absence of TNF-␣ (50 ng/ml) at 37°C for 9 h. Clarified lysates of transfected cells were prepared and analyzed by SteadyGlo luciferase assay reagents to determine ␥-secretase activity, and conditioned media were analyzed by the colorimetric A␤40 ELISA kit to measure secreted A␤40. Protein contents of cell lysates were determined by BCA protein assay reagent kit. A nonspecific oligonucleotide (Silencer Negative Control 1, catalogue no. AM4611, Ambion) that is not homologous to any known genes was used as a negative control to rule out nonspecific cellular events caused by the introduction of the siRNAs into cells. The transcript levels of JNKs in transfected cells were quantitated by real-time PCR with isoform-specific primer pairs to determine the knockdown efficiency of respective siRNAs.
Real-Time PCR to Quantitate the RNA Transcripts of JNK Isoforms
Total RNA of transfected cells was prepared by using TRIzol (Invitrogen) and was used to generate the first strand cDNA by SuperScript III First-strand cDNA Synthesis Kit (Invitrogen). Equivalent amounts of cDNA were used in quantitative PCR on DNA Engine Opticon Real-Time PCR Detection System (Bio-Rad, Hercules, CA) with following isoform-specific primer pairs: For JNK1, forward primer: 5Ј-GTTTGCCACAAAATCCTC-3Ј, reverse primer: 5Ј-CT-GAGAGCCATTGATCAC-3Ј; for JNK2, forward primer: 5Ј-TGAAACTTGC-CCACCCTT-3Ј, reverse primer: 5Ј-CCTTGGAATATCACACAACCTTTC-3Ј; and for JNK3, forward primer: 5Ј-CCAACATTGGATGTGAAAATTGCCT-3Ј, reverse primer: 5Ј-GGTACGCTCTCTTGGCATGT-3Ј (Katagiri et al., 2006) . The levels of human GAPDH transcripts (forward primer: 5Ј-GTGGTCTCCTCT-GACTTCAAC-3Ј and reverse primer: 5Ј-TCTCTTCCTCTTGTGCTCTTG-3Ј) were determined as an internal control. Cycling conditions were 95°C for 3 min, followed by 40 cycles of 94°C for 30 s, 55°C for 30 s, and 72°C for 1 min. For quantitation, the transcript levels of JNK isoforms were individually normalized to those of GAPDH. The data were expressed as the average (ϮSD) of triplicate measurements from three independent experiments.
Generation of a Stably Transfected Cell Line ␥NCT-36
The parental cell line ␥-30 and nicastrin expression vector were gifts kindly provided by Dr. Michael Wolfe (Brigham and Women's Hospital and Harvard Medical School, Boston, MA) , and the generation of CHO-derived ␥-30 cells was previously described . On the day of transfection, ␥-30 cells on a 10-cm dish with ϳ50% confluency were transfected with 5 g of pcDNA6-Nicastrin-V5-His (NCT-His) by FuGENE 6 transfection reagent according to the manufacturer's instructions. Transfected cells were cultured in DMEM supplemented with 10% FBS, 250 g/ml hygromycin, 250 g/ml zeocin, 2.5 g/ml puromycin, 200 g/ml geneticin (G418), and 5 g/ml blasticidin (DMEM-HZPGB), and single colonies resistant to antibiotic selection were isolated individually using cloning cylinders. Each of the independent cell lines was screened for the overexpression of His-tagged NCT. Individually isolated cell lines were plated into 12-well microplates in DMEM-HZPGB for 24 h. Cells were lysed in CHAPSO lysis buffer, and His-tagged NCT along with other ␥-secretase components was pulled down by HIS-Selected Cobalt Affinity Gel (Sigma). The affinity-purified proteins were resolved by SDS-PAGE and analyzed by Western blotting using rabbit anti-His antibody and rabbit anti-NCT antibody. The optimal cell line was the one exhibiting the highest amount of mature NCT. Based on this criterion, clone ␥NCT-36 was selected for future experiments (Figure 1 ).
TNF-␣-elicited Phosphorylation of NCT and PSI-1
On the day of the experiment, ␥NCT-36 cells (10 7 cells/plates) in 10-cm culture dishes were preincubated with DMEM containing 0.5% FBS at 37°C for 3 h, followed by the addition of TNF-␣ to a final concentration of 50 ng/ml and incubation at 37°C for various intervals. For the treatment with JNK inhibitor, ␥NCT-36 cells were pretreated with SP600125 (10 M) or DMSO (1%) for 30 min, followed by the addition of TNF-␣ (50 ng/ml) and incubation at 37°C for 1.5 h. Cells were harvested and lysed in a CHAPSO (1%)-containing buffer. Intact ␥-secretase complexes derived from clarified lysates of treated and untreated ␥NCT-36 cells were purified by HIS-Selected Cobalt Affinity Gel (Sigma) through their affinity with His-tagged NCT. Affinitypurified proteins were resolved by SDS-PAGE and analyzed by Western blotting with anti-phospho-serine/threonine antibody to determine the phosphorylation of immature and mature NCT (ϳ130 and 180 kDa) and full-length PS1 (ϳ50 kDa). The same blots were stripped and reprobed with anti-NCT and anti-PS1-NTF antibodies, respectively, to determine the levels of total NCT and PS1.
Cell-based ␥-Secretase Assays
The quantitative measurement of ␥-secretase activity using T20 cells has been previously described (Liao et al., 2004 (Liao et al., , 2007 . To examine TNF-␣-elicited effects on ␥-secretase, T20 cells stably transfected with C99-GV and Gal4-Luc were trypsinized and plated onto six-well microplates at 5 ϫ 10 5 cells/well with 1 ml/well serum-free DMEM. After incubation at 37°C overnight, cells were treated with 50 ng/ml TNF-␣ in DMEM containing 1 g/ml tetracycline and incubated at 37°C for various intervals as specified. Cells incubated with serum-free DMEM containing 1 g/ml tetracycline alone were used to define the basal level of ␥-secretase activity at each time point. To terminate the reactions, cells were harvested with PBS containing 20 mM EDTA and dissolved in 100 l of 1ϫ PLB. After the removal of cell debris by centrifugation, the activity of expressed luciferase reporter gene in clarified lysates was determined by mixing 20 l of lysates and 20 l of Steady-Glo luciferase assay reagent in a 96-well LumiNunc microplate (Nunc, Naperville, IL). Luminescence in individual microwells was determined by a VictorLight microplate luminometer (PerkinElmer, Waltham, MA) and subsequently normalized by the protein content of the corresponding lysates. The protein concentrations of clarified lysates were determined by the BCA protein assay kit as described in manufacturer's instructions. The normalized luciferase signal emitted by T20 cells in serum-free DMEM without tetracycline was referred to as onefold of activation. For treatments with chemical compounds, such as compound E, Figure 1 . Generation of a cell line stably overexpressing His-tagged NCT. Cells of the parental clone ␥-30 that overexpress human PS1, FLAG-tagged Pen-2, HA-tagged Aph1␣2, and APP were transfected with pcDNA6-NCT-V5-His (His-NCT). Transfected cells were cultured in DMEM supplemented with 10% FBS, 200 g/ml hygromycin, 250 g/ml, zeocin, 2.5 g/ml puromycin, 200 g/ml geneticin (G418), and 5 g/ml blasticidin (DMEM-HZPGB). (A) Each of the independent clones was isolated and screened for the expression of His-tagged NCT by Western blotting as described in Materials and Methods. Clarified lysates prepared from individual clones with equivalent amounts of protein were resolved by SDS-PAGE and analyzed by Western blotting with antiHis (top panel) and anti-NCT (bottom panel) antibodies. Clone numbers are denoted at the top of the blots. The optimal cell line was the one exhibiting the highest amount of mature NCT (mtNCT). Based on this criterion, clone 36 (␥NCT-36) was selected as the cellular model for future experiments. (B) Clarified lysates of ␥-30 and ␥NCT-36 cells were processed through HIS-Select Cobalt Affinity Gel, and affinitypurified proteins were resolved by SDS-PAGE and analyzed by Western blotting using rabbit anti-His antibody (top panel) and rabbit anti-NCT antibody (bottom panel). Both the His-tagged mtNCT and immature NCT (imNCT) in ␥NCT-36 cells, but not the endogenous NCT in the parental ␥-30 cells, can be efficiently pulled down by HIS-Select Cobalt matrix through affinity with the His tag of the recombinant NCT. (C) Clarified lysates of ␥NCT-36 cells were coimmunoprecipitated by an anti-HA antibody, and precipitated proteins were resolved by SDS-PAGE and analyzed by Western blotting to visualize NCT, PS1 (flPS1, PS1-NTF, and PS1-CTF), Aph1, and Pen-2 with specific antibodies. (D) Clarified lysates of ␥NCT-36 cells were processed through HIS-Select Cobalt Affinity Gel, and affinity-purified proteins were resolved by SDS-PAGE and analyzed by Western blotting to visualize NCT, PS1 (flPS1, PS1-NTF, and PS1-CTF), Aph1, and Pen-2 with specific antibodies. Blots shown in C and D prove successful isolation of the active ␥-secretase complexes, but do not necessarily reflect the actual stoichiometry of the enzyme components.
DAPT, MAP kinase inhibitors, compounds were added into the medium to a final concentration of 10 M or as specified, and the reactions were incubated at 37°C for various intervals as specified.
SDS-PAGE and Western Blot Analysis
Clarified cell lysates containing equivalent amounts of proteins were mixed with equal volumes of 2ϫ SDS sample buffer (125 mM Tris-HCl, pH 6.8, 4% SDS, 20% glycerol, 2% dithiothreitol, and 5% ␤-mercaptoethanol) and boiled at 100°C for 5 min. Denatured proteins were resolved in Tris glycine polyacrylamide gels (10 or 12%) and transferred electrophoretically to polyvinylidene difluoride membranes (Pall Corporation, East Hills, NY). Unbound areas on the membranes were blocked by a blocking buffer [3% BSA, 0.1% Tween-20 in TBS (TBST)] at room temperature for 1 h, followed by a brief rinse with TBST. Blocked membranes were probed with appropriate dilutions of primary antibody in the blocking buffer at room temperature for 1 h. After extensive washes with TBST to remove unbound primary antibody, washed membranes were incubated with appropriate HRP-conjugated secondary antibody in TBST at room temperature for 1 h. After the removal of unbound secondary antibody, antibody-reacted proteins were visualized by chemiluminescence using the SuperSignal West Femto or Dura reagents. Images were captured by and processed with ChemiGenius2 (Syngene, Frederick, MD). The antibodies used and their dilutions were as follows: anti-phospho-JNK and anti-JNK (Cell Signaling Technology, Beverly, MA), 1:1000; anti-phosphoSer/Thr (MPM-2), 1:4000; anti-PS1-NTF (N-19), 1:4000; anti-nicastrin, 1:4000; anti-A␤ (6E10), 1:1000; anti-APP-CTF, 1:4000; anti-GAPDH, 1:4000; HRPconjugated anti-mouse IgG (Amersham Biosciences, Piscataway, NJ) 1:10,000; and HRP-conjugated anti-rabbit IgG (Santa Cruz), 1:1000.
Site-directed Mutagenesis of Human PS1
The expression vector encoding the full-length human wild-type PS1 (pcDNA3.1-PS1) was kindly provided by Dr. Michael Wolfe (Brigham and Women's Hospital and Harvard Medical School, Boston, MA; . To generate a human PS1 mutant (PS1-S319AT320A) that lacks a putative phosphorylation site, adjacent serine and threonine (S 319 T 320 ) in PS1 predicted to be susceptible to phosphorylation (http://www.cbs.dtu.dk/ services/NetPhos/; the algorithm of this analysis can be found in Blom et al., 1999) were both replaced with alanines using the QuikChange site-directed mutagenesis kit according to the manufacturer's instructions. Two complementary oligonucleotides containing the desired mutations, flanked by unmodified nucleotide sequences, were synthesized. The paired primers for the generation of mutant PS1-S319AT320A were S319AT320A-forward (5Ј-AAG TAT AAT GCA GAA GCC GCA GAA AGG GAG TCA CAA-3Ј) and S319AT320A-reverse (5Ј-AGC TCG TGA CTC AGG TGC AGC GCG ATG AGG CCC TAG-3Ј). The underlined nucleotides denote the base changes made to incorporate the desired missense mutations. The mutagenized sequences were confirmed by DNA sequencing.
Microsomal Preparation of ␥-Secretase
The microsomal preparation and solubilization of ␥-secretase from ␥-30 and ␥NCT-36 cells were performed as previously described (Fraering et al., 2004) . A total of 10 8 ␥NCT-36 cells was harvested and resuspended in 10 ml of MES buffer (50 mM MES, pH 6.0, 150 mM NaCl, 5 mM MgCl 2 , 5 mM CaCl 2 , and the Complete protease inhibitor cocktail). The cells were lysed by being processed through a French Press (Thermo Fisher Scientific, Waltham, MA) once at 1500 psi. Nuclei and cellular debris were removed by centrifugation at 1500 g for 10 min, and the postnuclear supernatant was saved and centrifuged at 100,000ϫ g for 1 h at 4°C to pellet the total membranes (to yield the membrane preparation). Membrane pellets were resuspended in 2 ml of ice-cold MES buffer (0.1 M NaHCO 3 , pH 11.3) and were then repelleted at 100,000ϫ g for 1 h at 4°C to obtain the total microsomal membranes.
In Vitro Kinase Assay
JNK-dependent phosphorylation of ␥-secretase components was carried out as described previously (Wei et al., 1999) . In brief, the total microsomal membranes prepared from 10 8 ␥NCT-36 cells were resuspended in 0.6 ml of solubilization buffer (1% digitonin, 25 mM HEPES, pH 7.5, 150 mM NaCl, 5 mM MgCl 2 , 5 mM CaCl 2 , and the Complete protease inhibitor cocktail) and incubated at 4°C for 1 h, followed by centrifugation at 16,100ϫg for 10 min at 4°C to remove insoluble materials. ␥-Secretase complexes in the solubilized supernatant was isolated by HIS-Select Cobalt Affinity Gel (Sigma, 150 l of 50% suspension) through the affinity with His-tagged NCT and eluted by the elution buffer (50 mM sodium phosphate, pH 8.0, 0.3 M sodium chloride, 250 mM imidazole). Eluates of equivalent volume containing the affinity-precipitated ␥-secretase complexes were then incubated with 0.2 g of active JNK2 (Upstate) and 200 M ATP in kinase reaction buffer in the presence or absence of SP600125 (20 M) for 1.5 h at 30°C. Kinase reactions were terminated by the addition of SDS sample buffer. Proteins were resolved by 10 -12% SDS-PAGE, and phosphorylated ␥-secretase components were detected by Western blotting with anti-phospho-Ser/Thr antibodies. Duplicate blots were probed with anti-JNK2, anti-PS1, and anti-NCT antibodies for the identification of phosphorylated proteins.
To assess the JNK phosphorylation motif of PS1, synthetic peptide containing either the wild-type Ser 319 -Thr 320 motif (ST; NH 2 -KYNAESTERESQ-COOH) or an altered motif substituting both Ser 319 and Thr 320 residues with alanines (AA; NH 2 -KYNAEAAERESQ-COOH) were synthesized by Genesis Biotech (Taipei, Taiwan) and were used as competitors of in vitro JNK phosphorylation of PS1 as described above. Boldface letters denote the critical amino acids essential for JNK phosphorylation in wild-type PS1 and those substituted by alanines in mutant peptide.
Cell-Free ␥-Secretase Assay
To determine the microsomal ␥-secretase activity in response to JNK phosphorylation, we used a robust in vitro cell-free assay to assess the microsomal membrane-associated ␥-secretase activity (McLendon et al., 2000; Qin et al., 2003; Weggen et al., 2003) . Briefly, the total microsomal membranes derived from ␥NCT-36 or T20 cells were resuspended in 0.5 ml of kinase reaction buffer (25 mM Tris, pH 7.5, 5 mM ␤-glycerolphosphate, 2 mM 2-mercaptoethanol, 0.1 mM Na 3 VO 4 , 10 mM MgCl 2 , Complete protease inhibitor cocktail, and 0.02 mM EDTA). An aliquot of resuspended membrane (38 l) was incubated with 0.2 g of active JNK2 (Upstate) and 200 M ATP (to a final volume of 40 l) for 2 h at 37 or 4°C. Isolated ␥-secretase has been previously shown to exhibit a pH optimum at pH 7.5 and be able to cleave solubilized APP-CTFs in cell-free conditions (Esler et al., 2002; Fraering et al., 2004) . Reactions lacking JNK2 were included as controls. Kinase reactions were terminated by the addition of SDS sample buffer and boiling at 100°C for 10 min. Proteins were resolved by tricine (16.5%) SDS-PAGE, and the levels of C99, C83, and AICD were visualized by Western blotting using anti-A␤1-17 (clone 6E10, for C99) and anti-APP C-terminus (for C83 and AICD) antibodies, respectively.
Quantitative Densitometry and Statistical Analysis
Quantitative analysis of Western blots was conducted with the TotalLab v2.01 program by determining the relative density of the immunoreactive bands after acquisition of the blot image with ChemiGenius2 (Syngene). Phosphorylation levels were defined as the ratio of phospho-protein to total protein.
Results were expressed as the mean (ϮSD) of triplicate measurements from a representative experiment. Statistical analyses were done by a one-tailed Student's t test, and p Ͻ 0.05 was considered significant.
RESULTS
TNF-␣ Enhances the Phosphorylation of PS1 and NCT
We previously showed that TNF-␣ can activate ␥-secretase through a JNK-dependent MAPK pathway. Therefore, we sought to determine whether this TNF-␣-elicited regulation of ␥-secretase is due to JNK-dependent phosphorylation of this protease. To improve the efficiency of isolation of intact ␥-secretase complexes, we generated a CHO-derived cell line (␥NCT-36) from parental ␥-30 cells that constitutively coexpresses a His-tagged NCT along with human wild-type PS1, HA-tagged Aph-1␣2, FLAG-tagged Pen-2, and APP . Overexpression of His-tagged NCT in ␥NCT-36 cells was verified by the pulldown of recombinant NCT using the HIS-Select Affinity Gel chromatography (Figure 1B) . Nonglycosylated NCT, immature NCT, and mature NCT were all detected in this cell line, indicating that the maturation of recombinant NCT is not affected by the C-terminal 6XHis tag. We then demonstrated that functional ␥-secretase complexes could be formed in ␥NCT-36 cells, as evidenced by the successful isolation of all four constituents (PS1 heterodimers, NCT, Aph-1, and Pen-2) using coimmunoprecipitation with an anti-HA antibody (reactive with the HA-tagged Aph-1) and HIS-Select Cobalt Affinity Gel (Figure 1, C and D) .
To examine the TNF-␣-elicited phosphorylation of ␥-secretase, ␥NCT-36 cells were treated with TNF-␣ for various intervals. We found that the level of phosphorylation of full-length PS1 (flPS1) in TNF-␣-treated ␥NCT-36 cells was dramatically increased at 30 min, peaked at 1.5 h, and then returned to the basal level at 2.5 h ( Figure 2B, top panel) . Consistent with this profile, the phosphorylation level of mature NCT in TNF-␣-treated cells was significantly increased at 1.5 h and was sustained for up to 2.5 h ( Figure  2A, top panel) . The total protein levels of NCT and flPS1 remained unaffected (Figure 2A , bottom panel, and B, bottom panel).
Down-Regulation of JNKs Attenuates Endogenous and TNF-␣-elicited ␥-Secretase Activity
To verify that the TNF-␣-elicited stimulation of ␥-secretase activity is mediated through a JNK-dependent pathway, we used an RNA interference (RNAi) approach to determine whether specific down-regulation of JNK isoforms is sufficient to block TNF-␣-elicited stimulation of ␥-secretase. Isoform-specific siRNA oligonucleotides targeting JNK1, JNK2, and JNK3 (si-JNK1, si-JNK2, and si-JNK3) were transfected individually or combinatorially into T20 cells and were shown to significantly down-regulate the expression of the targeted JNK isoform(s) ( Figure 3B ). The knockdown efficiency of these isoform-specific siRNAs ranged from 40 to 80% as estimated by real-time PCR. We found that TNF-␣-elicited stimulation of ␥-secretase was significantly attenuated by the down-regulation of selective JNKs and was completely abolished by the combined down-regulation of JNK1 and JNK2, whereas ␥-secretase activity in mock-transfected cells was elevated ϳ100% by the stimulation of TNF-␣ ( Figure 3A) . In the absence of TNF-␣, the down-regulation of JNKs also resulted in a significant reduction in endogenous basal ␥-secretase activity, suggesting that JNKs might govern the function of this protease. Consistently, the levels of secreted A␤40 from cells that are transfected with JNKtargeting siRNAs were significantly reduced ( Figure 3C ). The attenuation of ␥-secretase activity through the downregulation of JNK, reminiscent of the effect of the JNK antagonist SP600125 (Liao et al., 2004) , is consistent with the model that JNKs play a critical role in maintaining the homeostasis of endogenous ␥-secretase activity.
Inhibition of JNK Significantly Attenuates TNF-␣-elicited Phosphorylation of NCT and PS1
To further verify the critical role of JNKs in TNF-␣-elicited phosphorylation of PS1 and NCT, ␥NCT-36 cells were pretreated with SP600125, a specific JNK inhibitor, in the presence of TNF-␣. We found that the TNF-␣-induced phosphorylation of both NCT and full-length PS1 was suppressed by SP600125 down to the basal level while the total protein levels of NCT and flPS1 were unchanged (Figure 4) . Active JNK was copurified with ␥-secretase complexes, suggesting that, in the presence or absence of extracellular stimuli, JNK can intimately associate with ␥-secretase in a cellular environment ( Figure 4A ). Together, these findings strongly suggest that JNK is a crucial mediator of TNF-␣-elicited stimulation of ␥-secretase.
JNK Can Directly Interact with ␥-Secretase and Promote the Phosphorylation of NCT and PS1
To determine whether ␥-secretase can be directly phosphorylated by JNK, we used an in vitro kinase assay in which purified active JNK2 could directly interact with intact ␥-secretase complexes isolated from the microsomal membranes of ␥NCT-36 cells. Solubilized ␥-secretase purified by HIS-Select Cobalt Affinity Gel chromatography was incubated with active JNK2 recombinant protein with or without SP600125 at 30°C for 1 h. Consistent with our results obtained from cell-based assays, we found that active JNK2 can directly phosphorylate NCT and PS1 in vitro, inducing ϳ127 and 77% increases in the levels of phosphorylation of NCT and flPS1, respectively ( Figure 5 ). This JNK2-induced phosphorylation of ␥-secretase can be completely abolished by SP600125 that can also suppress the autophosphorylation of JNK ( Figure 5B ). The total levels of NCT, JNK2, and flPS1 indicate consistent protein loading in these in vitro kinase assays ( Figure 5A ). Given that JNKs can also copurify with ␥-secretase complexes, it is plausible that JNKs can physically interact with and modify this protease to promote its enzymatic activity.
Active JNK2 Promotes ␥-Secretase-catalyzed Processing of APP-C99 and APP-C83 to Enhance the Production of AICD
To further substantiate that JNK-dependent phosphorylation of ␥-secretase could affect its proteolytic activity, solubilized membrane preparation of ␥NCT-36 containing ␥NCT-36 cells (10 7 cells/plates) in 10-cm culture dishes were preincubated with DMEM containing 0.5% FBS at 37°C for 3 h, followed by the addition of TNF-␣ to a final concentration of 50 ng/ml and incubation at 37°C for various intervals. Intact ␥-secretase complexes were purified by HIS-Selected Cobalt Affinity Gel chromatography through the His-tagged NCT. Affinity-purified proteins were resolved by SDS-PAGE and analyzed by Western blotting with anti-phospho-serine/threonine antibody to determine the phosphorylation of mature and immature NCT (phospho-mtNCT and phospho-imNCT, top panel, A) and full-length PS1 (phospho-flPS1, top panel, B). After stripping, the top and lower halves of the blot were reprobed with anti-NCT and anti-PS1-NTF antibodies, respectively, to determine the levels of total NCT (mtNCT and imNCT, bottom panel, A) and PS1 (flPS1, bottom panel, B). Quantitative data are expressed as the mean (ϮSD) from three independent experiments and analyzed by Student's t test. *pϽ 0.05 denotes versus control at the same time. mtNCT, mature NCT; imNCT, immature NCT; flPS1, full-length PS1. Alteration in phosphorylation of mt-NCT was noted in the control samples of 2.5 h, but could not be consistently observed.
␥-secretase and APP was incubated with active JNK2 recombinant protein at 30 or 4°C. Our data showed that, in the presence of active JNK2, ␥-secretase-mediated processing of the APP C-terminal fragments, APP-C99 and APP-C83, is significantly enhanced, evidenced by the diminished accumulation of C99 and C83 ( Figure 6A ). This JNK2-elicited stimulation was even more pronounced when ␥-secretase derived from T20 cells that overexpress C99 was allowed to process C99 in the presence of active JNK2 ( Figure 6B ). In this experiment, the production of APP intracellular domain (AICD) resulting from ␥-secretase-mediated processing of C99 and C83 was significantly increased in the presence of active JNK2. Addition of the ␥-secretase inhibitor DAPT completely blocked the processing of C99 and C83, whereas control reactions in the absence of active JNK2 produced a modest amount of AICD ( Figure 6C ). These findings strongly support a model in which JNKs directly interact with and phosphorylate ␥-secretase to augment its enzymatic activity.
A Putative Phosphorylation Site (Ser 319 Thr 320 ) in PS1 Is Required for TNF-␣-elicited Stimulation of ␥-Secretase Activity
To elucidate the molecular mechanism underlying the JNKdependent regulation of ␥-secretase, it is necessary to identify the critical residues in NCT and PS1 that are subject to JNK-dependent phosphorylation. By using the algorithm provided by the NetPhos 2.0 Server (http://www. cbs.dtu.dk/services/NetPhos/; Blom et al., 1999) to predict conserved Ser/Thr phosphorylation sites, we identified an adjacent Ser/Thr pair (S 319 T 320 ) to be a likely candidate for phosphorylation by JNK. We thus hypothesized that a mutant PS1 lacking this putative phosphorylation site would be unresponsive to TNF-␣-elicited stimulation. To test this hypothesis, we created a mutant PS1 (PS1-S319A/T320A) by simultaneously replacing the S 319 and T 320 residues in human PS1 with alanines using site-directed mutagenesis.
To examine whether the mutant PS1 could affect ␥-secretase activity in response to TNF-␣ stimulation, ␥-secretase activity in T20 cells transfected with either an empty vector, wild-type human PS1 (PS1-WT), or PS1-S319A/T320A was assessed in the presence or absence of TNF-␣. As shown in Figure 7A , the increase in ␥-secretase activity that is normally triggered by TNF-␣ was completely eradicated in cells expressing PS1-S319A/T320A, but not PS1-WT. Furthermore, these results revealed that cells expressing PS1-S319A/T320A exhibit similar levels of ␥-secretase activity in the presence or absence of SP600125, consistent with the model that TNF-␣-eclicited stimulation of ␥-secretase is mediated by the JNK pathway. Our data suggest that S 319 T 320 in PS1 is targeted by JNK in response to TNF-␣-triggered regulation of ␥-secretase.
Mutant PS1 (PS1-S319A/T320A) Can Prevent the TNF-␣-stimulated Processing of Notch⌬E by ␥-Secretase
To ascertain whether JNK-dependent phosphorylation of PS1 can modulate the catalytic activity of ␥-secretase inde- pendent of substrate selectivity, N7 cells were transfected with an empty vector, PS1-WT, or PS1-S319A/T320A, followed by the treatments with TNF-␣. We found that the TNF-␣-stimulated processing of Notch⌬E (N⌬E) by ␥-secretase in cells expressing mutant PS1-S319A/T320A is dramatically reduced, as evidenced by the decreased production of Notch intracellular domain (NICD), whereas endogenous ␥-secretase cleavage of N⌬E remains unaffected, as judged from comparison to the amount of NICD produced in cells transfected with PS1-WT (Figure 7 , B and C). Consistent with its effect on ␥-secretase cleavage of APP-C99 in T20 cells cells/plates) in 10-cm culture plates were preincubated with DMEM containing 0.5% FBS at 37°C for 3 h and were pretreated with vehicle alone (0.1% DMSO) or 10 M SP600125, a JNK inhibitor, at 37°C for 30 min, followed by the addition of TNF-␣ to a final concentration of 20 ng/ml and an additional incubation at 37°C for 1.5 h. ␥-Secretase complexes in cell lysates were purified by HISSelected Cobalt Affinity Gel through the affinity of the His-tagged NCT. Affinity-purified proteins were resolved by SDS-PAGE and analyzed by Western blotting. The phosphorylation levels of NCT and PS1 were visualized by an anti-phospho-serine/threonine antibody, whereas those of JNK by anti-phospho-JNK. The same blots were stripped and reprobed with anti-NCT, anti-PS1-NTF, and anti-total JNK antibodies to determine the levels of total NCT, PS1, and JNK. mtNCT, mature NCT; imNCT, immature NCT; flPS1, full-length PS1. Asterisk denotes the mobility shift of phosphorylated flPS1. (B) The levels of phosphorylated mtNCT and flPS1 were determined by densitometry and normalized by those of total mt-NCT and flPS1, respectively. The normalized phosphorylation levels of mtNCT and flPS1 in untreated cells are referred to as 100% relative phosphorylation, respectively. Results are expressed as the mean (ϮSD) phosphorylation levels of mtNCT (solid bar) and flPS1 (hatched bar) from three independent experiments and analyzed by Student's t test. *p Ͻ 0.05. The levels of phosphorylated and total proteins were determined by densitometry. The ratio of phosphorylated versus total protein (NCT and flPS1) in the control reaction was referred to as 100% relative phosphorylation. Quantitative data are shown as the mean (ϮSD) phosphorylation of mtNCT and flPS1 from three independent experiments and analyzed by Student's t test. *p Ͻ 0.05.
( Figure 7A ), these results suggest that ectopically expressed PS1-S319A/T320A can be processed and assembled into active ␥-secretase complexes just as well as the wild-type PS1, as evidenced by the unchanged basal activity of endogenous ␥-secretase. These findings substantiate that mutant PS1 defective in a JNK phosphorylation site can completely abolish the TNF-␣-induced increase in ␥-secretase activity independent of its available substrates. It is thus the deficiency in JNK phosphorylation of PS1 that attributes to the blockade of TNF-␣-elicited effects on ␥-secretase activity.
To further confirm that the S 319 and T 320 residues of PS1 are required for JNK phosphorylation, we generated one synthetic peptide (ST) encompassing the wild-type PS1 sequence flanking the S 319 T 320 motif and another synthetic Terminated reaction mixtures were resolved by tricine (16.5%) SDS-PAGE, and the levels of C99 and C83 were analyzed by Western blotting by using anti-A␤1-17 (clone 6E10, for C99) and anti-APP C-terminus (CЈAPP, for C83) antibodies, respectively. (B) Equivalent amounts of resuspended microsomal membranes that were derived from T20 cells and enriched with membrane-tethered ␥-secretase and C99-GV were incubated with 200 ng active JNK2 and 200 M ATP in a kinase buffer for 4 h at 37 or 4°C. Reactions lacking JNK2 were included as controls. Terminated reaction mixtures were resolved by tricine (10%) SDS-PAGE, and the levels of C99 were analyzed by Western blotting by using anti-A␤1-17 (clone 6E10). The levels of caveolin-1 were determined as a membrane protein loading control. (C) Equivalent amounts of resuspended microsomal membranes that were derived from ␥NCT-36 cells and enriched with membrane-tethered ␥-secretase, and APP-CTFs were incubated with 200 ng active JNK2 and 200 M ATP in a kinase buffer in the presence of 0.1% DMSO or 10 M DATP for 2 h at 30 or 4°C.
Reactions lacking JNK2 were included as controls. Terminated reaction mixtures were resolved by tricine (16.5%) SDS-PAGE, and the levels of AICD were analyzed by Western blotting by using an anti-APP C-terminus (CЈAPP) antibody. Molecular weight markers (MW, in kDa) are denoted to the left of each immunoblot.
Figure 7.
One putative phosphorylation site in human PS1, S 319 T 320 , is required for the TNF-␣-elicited stimulation of ␥-secretase activity. (A) T20 cells (7.5 ϫ 10 5 cells/well) in six-well microplates were transfected with 1 g/well of empty vector (Mock), wild-type PS1 (PS1-WT), or mutant PS1 (PS1-S 319 AϩT 320 A) in the presence of 0.1 g/well of pRL-TK for 24 h at 37°C, followed by replacing the media with DMEM containing 0.5% FBS and 1 g/ml tetracycline in the presence of 0.1% DMSO (solid bar, striped bar) or 10 M SP600125 (hatched bar) and an additional incubation at 37°C for at least 3 h. Transfected cells were then treated with 50 ng/ml TNF-␣ in DMEM containing 0.5% FBS at 37°C overnight (striped bar and hatched bar). ␥-Secretase activity was determined by using the Dual-Glo luciferase assay reagents. Normalized luciferase signals from vehicle-treated cells were referred to as 100% relative ␥-secretase activity. Data are shown as the mean (ϮSD) of triplicate measurements from three independent experiments and analyzed by Student's t test. *p Ͻ 0.05. (B) N7 cells (5 ϫ 10 5 cells/well) in six-well tissue culture plates were transfected with 1 g/well of empty vector (Mock), PS1-WT, or PS1-S319AT320A for 24 h at 37°C, followed by the replacement of medium with DMEM containing 0.5% FBS and an additional incubation for at least 3 h at 37°C. Transfected cells were treated with vehicle alone or 50 ng/ml TNF-␣ and incubated at 37°C overnight. Clarified lysates with equivalent amounts of proteins were resolved by SDS-PAGE and analyzed by Western blotting. The production of NICD was visualized by anti-Notch-(Val 1744 ) antibody (top panel). The levels of GAPDH were determined as a protein loading control (bottom panel). (C) The levels of NICD and GAPDH were determined by densitometry. The ratio of NICD versus GAPDH in untreated mock-transfected cells was referred to as 100% relative NICD production. Quantitative data are shown as the mean (ϮSD) NICD production from three independent experiments and analyzed by Student's t test. *p Ͻ 0.05. peptide (AA) whose S 319 T 320 residues are simultaneously replaced with alanines. Using both synthetic peptides as competitors in the in vitro JNK kinase assay, we found that JNK phosphorylation of PS1 (both full-length PS1 and PS1-CTF) is completely blocked by the wild-type synthetic peptide ST, but not by the mutant peptide AA, reminiscent of the inhibitory effect of SP600125 (Figure 8) . Together, our data identify S 319 and T 320 in PS1 as an essential motif for JNK phosphorylation elicited by TNF-␣ signaling.
JNK-dependent Phosphorylation of PS1 Correlates with the Enhanced Stability of PS1-CTF
Given that the phosphorylation of full-length PS1 by JNK is important for its proteolytic activity and that the S 319 T 320 phosphorylation site of PS1 is localized near an endoproteolytic site within the protein's intracellular hydrophilic loop domain, we hypothesized that JNK phosphorylation of PS1 might promote endoproteolysis of full-length PS1 to give an active heterodimer form of PS1, which is a prerequisite for the formation of functional ␥-secretase complexes (Iwatsubo, 2004) . Alternatively, JNK phosphorylation of PS1-S 319 T 320 might simply prolong the stability of PS1-CTF. To determine whether the phosphorylation of PS1 by JNK influences the endoproteolysis of PS1 or the stability of PS1-CTF, we first examined the levels of full-length PS1, PS1-NTF, and PS1-CTF in response to JNK phosphorylation. The formation of PS1-NTF and PS1-CTF relative to the fulllength PS1 in an in vitro kinase assay was assessed. We found that PS1 phosphorylation by an active recombinant JNK2 in a cell-free condition can significantly increase the levels of PS1-CTF relative to those of full-length PS1, whereas both the JNK inhibitor SP600125 and the wild-type synthetic peptide ST, but not the mutant peptide AA, can prevent the JNK-induced increase in the levels of PS1-CTF ( Figure 9A ). However, the levels of PS1-NTF relative to full-length PS1 in the same reactions were not significantly altered by JNK phosphorylation of PS1 ( Figure 9B ). Because JNK phosphorylation did not induce concomitant increases in the levels of PS1-CTF and PS1-NTF, these findings favor a model in which JNK phosphorylation of PS1 at S 319 T 320 enhances the stability of phosphorylated PS1-CTF. Furthermore, we observed a significant increase in the ratio of PS1-CTF versus full-length PS1 in cells overexpressing wildtype PS1 (PS1-WT), but not mutant PS1 (PS1-S319A/T320A) that is defective in JNK phosphorylation ( Figure 9C ), suggesting that the stability of mutant PS1-CTF is significantly reduced. Our findings clearly demonstrate that JNK phosphorylation of PS1 at the Ser 319 Thr 320 motif could be crucial for the stability of PS1-CTF in vivo, substantiating the biological significance of TNF-␣-elicited JNK activation in the regulation of ␥-secretase.
DISCUSSION
The generation of A␤ through the secretase-mediated processing of APP has long been thought to be causal for the neuropathology and cognitive decline in AD. Our previous study showed that activation of JNK is essential for the cytokine-elicited stimulation of ␥-secretase activity (Liao et al., 2004) . Here, we provide new evidence demonstrating that TNF-␣ signaling can alter the phosphorylation status of PS1 and NCT, two major constituents of ␥-secretase, concomitant with stimulation of ␥-secretase activity. The newly established stable cell line ␥NCT-36 that stably overexpresses human wild-type PS1, NCT, Aph-1␣, Pen-2, and APP provides a cellular model with unprecedented resolution of the posttranslational modifications to the components of ␥-secretase in response to such extracellular stimuli as TNF-␣. Using genetic and biochemical approaches, we clearly demonstrate that TNF-␣-induced stimulation of ␥-secretase is mediated through JNK phosphorylation of PS1 and NCT. We further identify a novel JNK phosphorylation site within human PS1 that is essential for both TNF-␣- Reactions lacking JNK2 were included as negative controls (C), whereas those containing active JNK2 only as positive controls (ϩ). Terminated reaction mixtures were resolved by SDS-PAGE, and the levels of phosphorylated full-length PS1 (flPS1), phosphorylated PS1-CTF, total flPS1, and total PS1-CTF were analyzed by Western blotting by using anti-phospho-serine/phosphothreonine (clone MPM-2, for phospho-flPS1 at top panel and phospho-PS1-CTF at lower middle panel), anti-PS1-NTF (for total flPS1, upper middle panel), and anti-PS1-loop (for total PS1-CTF, bottom panel) antibodies, respectively. Arrow denotes the phosphorylated flPS1 and PS1-CTF, respectively. (B) The levels of phosphorylated flPS1, phosphorylated PS1-CTF, total flPS1, and total PS1-CTF were determined by densitometry. The ratios of phospho-flPS1 versus total flPS1 (solid bar) and phospho-PS1-CTF versus total PS1-CTF (shaded bar) in control reactions lacking JNK2 was referred to as 100% relative phosphorylation of PS1 (histogram). Quantitative data are shown as the mean (ϮSD) PS1 phosphorylation from at least four independent experiments and analyzed by Student's t test. *p Ͻ0.05 versus negative control (C).
# p Ͻ 0.05 versus positive control (؉).
induced stimulation of ␥-secretase and the stability of PS1-CTF, correlating the JNK-dependent phosphorylation and the assembly of ␥-secretase complexes.
Accumulated evidence reveals that JNKs play an important role in AD pathogenesis and that the application of JNK inhibitors could help alleviate the symptoms of AD (Manning and Davis, 2003; Zhu et al., 2004b) . Our data showing that down-regulation of JNKs by RNAi can dramatically attenuate both TNF-␣-elicited and endogenous ␥-secretase activity to reduce A␤ production (Figure 3) , reminiscent of the inhibitory effect of the JNK-specific inhibitor SP600125, further support the neurodegenerative effects of JNKs on AD. Previous studies have demonstrated that down-regulation of JNK by RNAi can also effectively reduce the stressinduced phosphorylation of JNK (Nguyen et al., 2005; Tong et al., 2007) , substantiating our data that the partial depletion of specific JNK isoforms could critically impair TNF-␣-elicited regulation of ␥-secretase. The JNK pathway is associated with age-dependent amyloid plaque deposition and the loss of synaptophysin in a Tg2576/PS1 double transgenic AD mouse model (Otth et al., 2003) . It is thus conceivable that all three major JNK isoforms (JNK1, JNK2, and JNK3) could be affected in AD (Shoji et al., 2000; Ferrer et al., 2001; Pei et al., 2001; Zhu et al., 2001) . JNK1 and JNK2 exhibit a broad tissue distribution, whereas JNK3 is predominantly localized to pyramidal neurons in the CA1 and CA2 regions of the hippocampus, the neocortex, and the testes (Kuan et al., 1999) . Given that different JNK isoforms could have distinct biological functions (Davis, 2000) , it is possible that they might not all participate to the same extent in mediating TNF-␣-elicited regulation of ␥-secretase. Recent studies have demonstrated that JNK2 and JNK3 are the primary mediators of MPTP-induced death of dopaminergic neurons, implicating a JNK-dependent neurodegeneration in the pathogenesis of Parkinson's disease (Hunot et al., 2004) . In addition, JNK3 has also been implicated as the principal mediator of ischemia-hypoxia-associated neuronal death (Kuan et al., 2003) . Although JNK1/2/3 are all involved in the regulation of both endogenous and TNF-␣-elicited ␥-secretase activity, our data suggest that JNK1/2 are the primary mediators of TNF-␣'s stimulatory effects, further substantiating the idea that individual JNK isoforms could have distinct roles in a variety of biological functions.
Our present data provide evidence for the first time that JNKs can directly interact with ␥-secretase (Figure 5) , further strengthening the importance of the JNK pathway in the regulation of APP processing. In cultured ␥NCT-36 cells, JNK can also be coprecipitated with NCT, PS1, and the full-length APP (data not shown), which can be suppressed by the inhibition of JNK, suggesting that phosphorylation of ␥-secretase by JNK could affect the interactions between this protease and its substrates. Given that JNK can also phosphorylate APP at Thr 668 (Standen et al., 2001) , our results clearly suggest that ␥-secretase could physically interact with APP and JNK. Because A␤-induced activation of JNK plays a critical role in A␤-dependent neuronal death in AD (Morishima et al., 2001) , it is likely that phosphorylation of APP and ␥-secretase by JNK could synergistically promote the processing of APP through simultaneously turning APP into a favorable substrate (phosphorylated APP) and elevating ␥-secretase activity, constituting a positive feedback to potentiate the A␤-elicited neurotoxicity. We identify a novel JNK phosphorylation site within PS1 at Ser 319 (Kirschenbaum et al., 2001b; Lau et al., 2002; Fluhrer et al., 2004) . Despite the marginal effect of phosphorylation of PS1 by PKC on A␤ production (Seeger et al., 1997; Walter et al., 1997) , phosphorylation of PS1 by various kinases at distinct residues has been shown to affect the binding of PS1 to ␤-catenin and its nuclear signaling, PS1-CTF protein stability, and the caspase cleavage of PS1 (Kirschenbaum et al., 2001a; Lau et al., 2002; Fluhrer et al., 2004; Prager et al., 2007) . Consistent with previous findings, our present data, that modulation of ␥-secretase activity is susceptible to TNF-␣-elicited JNK phosphorylation of PS1 at Ser 319 Thr 320 , suggest that the processing, stability, and function of PS1 are regulated in a complex manner.
We present evidence that the deficiency in JNK phosphorylation of PS1 at S 319 T 320 could result in reduced levels of PS1-CTF, but not PS1-NTF, implying that the stability of PS1 heterodimers could be subject to the regulation elicited by extracellular stimuli. This finding is in accordance with the observation that the stabilities of the individual PS1 fragments appear to be regulated independently (Kirschenbaum et al., 2001a) . Of note, cells expressing the PS1-S319A/T320A mutant exhibit consistent endoproteolysis of PS1 and have normal basal ␥-secretase activity just like those expressing wild-type PS1 do. The processing of full-length PS1 into PS1-NTF and PS1-CTF fragments is a prerequisite for the formation of stable heterodimers that are incorporated into high molecular mass complexes (Iwatsubo, 2004) . Although the nonconserved hydrophilic loop domain of PS1 has been shown to be dispensable for PS1 endoproteolysis (Saura et al., 2000) , recent evidence demonstrates that phosphorylation of this domain by GSK-3␤ could induce a structural change in PS1 (Prager et al., 2007) . Accordingly, phosphorylation of the hydrophilic loop domain by JNK might also induce a conformational change in PS1-CTF, augmenting its stability. It is thus plausible that phosphorylated PS1-CTF could effectively interact with PS1-NTF to form PS1-NTF/ CTF heterodimers and render ␥-secretase complexes with higher catalytic activities. Alternatively, phosphorylation of PS1 by JNK could affect its interaction with other intracellular signaling modulators that in turn control ␥-secretase activity. Both scenarios highlight the functional role of TNF-␣-elicited phosphorylation of PS1 and NCT by JNK in the regulation of ␥-secretase.
Together, our results demonstrate that TNF-␣-elicited activation of ␥-secretase is due to the JNK-dependent phosphorylation of PS1 and NCT, possibly through a direct interaction between JNK and ␥-secretase. Our data also propose that S 319 T 320 is the major JNK phosphorylation site in PS1. The exact role of JNK phosphorylation of PS1 and NCT and how such events can affect the protein-protein interactions among various ␥-secretase constituents warrants further investigation. Finally, molecules able to block phosphorylation of PS1 by JNK might inhibit the ␥-secretase-mediated processing of APP and possibly provide the basis for the development of novel anti-AD drugs.
